Disparity of race reporting in US Food and Drug Administration drug approvals for urinary system cancers from 2006 to 2021

被引：3
|
作者：
Glover, Michael [1 ]
Hui, Gavin [1 ]
Chiang, Ryan [1 ]
Savage, Philip [2 ]
Krell, Jonathan [3 ]
Julve, Maximilian [3 ]
Grivas, Petros [4 ]
Lythgoe, Mark [3 ]
Khaki, Ali Raza [5 ]
机构：
[1] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[2] Brighton & Sussex Univ Hosp NHS Trust, Dept Oncol, Brighton, E Sussex, England
[3] Hammersmith Hosp, Imperial Coll London, Dept Surg & Canc, London, England
[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Med, Div Med Oncol,Clin Res Div, Seattle, WA USA
[5] Stanford Univ, Dept Med, Div Oncol, Stanford, CA USA
来源：
BJU INTERNATIONAL | 2022年 / 129卷 / 02期
关键词：
D O I：
10.1111/bju.15629
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 170
页数：3
相关论文
共 50 条
  • [1] Use of Extrapolation in New Drug Approvals by the US Food and Drug Administration
    Feldman, Daniel
    Avorn, Jerry
    Kesselheim, Aaron S.
    JAMA NETWORK OPEN, 2022, 5 (04) : E227958
  • [2] Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration
    Jiao, Kuo
    Gupta, Ravi
    Fox, Erin
    Kesselheim, Aaron
    Ross, Joseph S.
    JAMA NETWORK OPEN, 2019, 2 (10)
  • [3] Review of Evidence Supporting 2022 US Food and Drug Administration Drug Approvals
    Kaplan, Robert M.
    Koong, Amanda J.
    Irvin, Veronica
    JAMA NETWORK OPEN, 2023, 6 (08) : e2327650
  • [4] Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006–2020
    M. P. Lythgoe
    J. Krell
    P. Savage
    V. Prasad
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 1208 - 1211
  • [5] Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
    Loree, Jonathan M.
    Anand, Seerat
    Dasari, Arvind
    Unger, Joseph M.
    Gothwal, Anirudh
    Ellis, Lee M.
    Varadhachary, Gauri
    Kopetz, Scott
    Overman, Michael J.
    Raghav, Kanwal
    JAMA ONCOLOGY, 2019, 5 (10)
  • [6] FOOD AND DRUG ADMINISTRATION DRUG EXPERIENCE REPORTING SYSTEM
    ESCH, AF
    JOURNAL OF CHEMICAL DOCUMENTATION, 1969, 9 (02): : 66 - &
  • [7] Limitations in Clinical Trials Leading to Anticancer Drug Approvals by the US Food and Drug Administration
    Hilal, Talal
    Gonzalez-Velez, Miguel
    Prasad, Vinay
    JAMA INTERNAL MEDICINE, 2020, 180 (08) : 1108 - 1115
  • [8] Single-arm trials for US Food and Drug Administration cancer drug approvals
    Nierengarten, Mary Beth
    CANCER, 2023, 129 (11) : 1626 - 1627
  • [9] Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006-2020
    Lythgoe, M. P.
    Krell, J.
    Savage, P.
    Prasad, V.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1208 - 1211
  • [10] NOVEL DRUG APPROVALS BY THE US FOOD AND DRUG ADMINISTRATION IN RARE DISEASES: FINDINGS FROM 2020-2023
    Dubey, A.
    Gupta, P.
    Ranjan, N.
    Ray, P.
    Kumar, J.
    Shaikh, J.
    VALUE IN HEALTH, 2024, 27 (06) : S216 - S216
12345